Erdaini
Erdafitinib
- Strength
- 3mg/4mg/5mg
- Manufacturer
- TLPH Pharma
- Availability
- Available to source
Erdafitinib 3mg/4mg/5mg — Tablet, 28's Pot
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: Balversa by Janssen · Manufacturer: TLPH Pharma. Indication & Dosage: Erdaini (Erdafitinib), generic Balversa is a prescription medicine used to treat adult patients with locally advanced or metastatic Urothelial Carcinoma (bladder cancer) that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. Erdaini manufactured by TLPH Pharma in Laos. Erdafitinib has to take orally once daily with or without food. Side Effects: The most common adverse reactions of Erdafitinib are: Nausea , vomiting , mouth sores/pain , change in how food tastes, abdominal pain, diarrhea, constipation, loss of appetite, weight loss, tiredness, dry mouth/skin, or muscle/joint pain. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
